InsidersTradesSigma
Total declarations
Company
▲ Purchases (30 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
30
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Londoner Kenneth l, Founder, Chairman & Chief Executive Officer. Director active across 1 company, notably BioSig Technologies, Inc.. Aggregated, 44 filings have been logged. Split: 30 buys · 0 sell. Total volume traded: €262k. History available since 26 May 2021. The latest transaction was filed on 30 November 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Londoner Kenneth l
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations44 total
219,700 shares0Common StockSEC:0001493152-23-043614:0
10,000 shares@ US$1.241.7% of flowCommon StockSEC:0001185185-23-000633:0
Canonical exit: 11 Sept 2023 (T+90)
2,000 shares@ US$1.100.3% of flowCommon StockSEC:0001185185-23-000631:0
Canonical exit: 10 Sept 2023 (T+90)
1,000 shares@ US$1.560.2% of flowCommon StockSEC:0001185185-23-000625:0
Canonical exit: 29 Aug 2023 (T+90)
576,000 shares0Common StockSEC:0001185185-23-000462:0
7,006 shares@ US$0.840.9% of flowCommon StockSEC:0001185185-22-001087:0
Canonical exit: 7 Dec 2022 (T+90)
500 shares@ US$1.0990.1% of flowCommon StockSEC:0001185185-22-001075:0
Canonical exit: 6 Dec 2022 (T+90)
3,000 shares@ US$1.090.5% of flowCommon StockSEC:0001185185-22-001067:0
Canonical exit: 1 Dec 2022 (T+90)
17,240 shares@ US$1.08492.7% of flowCommon StockSEC:0001185185-22-001057:0
Canonical exit: 30 Nov 2022 (T+90)
1,000 shares@ US$1.080.2% of flowCommon StockSEC:0001185185-22-001031:0
Canonical exit: 27 Nov 2022 (T+90)
7,400 shares@ US$1.191.3% of flowCommon StockSEC:0001185185-22-001025:0
Canonical exit: 23 Nov 2022 (T+90)
5,000 shares@ US$1.050.8% of flowCommon StockSEC:0001185185-22-001004:0
Canonical exit: 21 Nov 2022 (T+90)
3,000 shares@ US$1.010.4% of flowCommon StockSEC:0001185185-22-000976:0
Canonical exit: 17 Nov 2022 (T+90)
500 shares@ US$0.880.1% of flowCommon StockSEC:0001185185-22-000970:0
Canonical exit: 15 Nov 2022 (T+90)
3,000 shares@ US$0.9220.4% of flowCommon StockSEC:0001185185-22-000961:0
Canonical exit: 14 Nov 2022 (T+90)
9,300 shares@ US$1.151.6% of flowCommon StockSEC:0001185185-22-000699:0
Canonical exit: 23 Aug 2022 (T+90)
8,744 shares@ US$1.0981.4% of flowCommon StockSEC:0001185185-22-000692:0
Canonical exit: 22 Aug 2022 (T+90)
3,650 shares@ US$1.130.6% of flowCommon StockSEC:0001185185-22-000688:0
Canonical exit: 18 Aug 2022 (T+90)
20,000 shares0Common StockSEC:0001185185-22-000002:0
2,636 shares@ US$2.812.4% of flowCommon StockSEC:0001185185-21-001398:0
Canonical exit: 19 Dec 2021 (T+90)
3,200 shares@ US$3.42691.4% of flowCommon StockSEC:0001185185-21-001239:0
Canonical exit: 24 Aug 2021 (T+90)
3,000 shares@ US$3.671.5% of flowCommon StockSEC:0001185185-21-001247:0
Canonical exit: 1 Sept 2021 (T+90)
4,000 shares@ US$3.90752.0% of flowCommon StockSEC:0001185185-21-001245:0
Canonical exit: 31 Aug 2021 (T+90)
1,000 shares@ US$3.320.4% of flowCommon StockSEC:0001185185-21-001235:0
Canonical exit: 23 Aug 2021 (T+90)
4,200 shares@ US$3.52161.9% of flowCommon StockSEC:0001185185-21-001241:0
Canonical exit: 25 Aug 2021 (T+90)
25 of 44 declarations
About Londoner Kenneth l
LONDONER KENNETH L is Founder, Chairman & Chief Executive Officer and Chief Executive Officer of BioSig Technologies, Inc. He has 44 filings in total, and across the sampled recent filings, purchases total EUR 261636 and sales total EUR 0, over the period from 2021-05-26 to 2023-12-04.
